Cargando…

Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708

Detalles Bibliográficos
Autores principales:	Kruszelnicka, Olga, Rakowski, Tomasz, Surdacki, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Online Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781442/ https://www.ncbi.nlm.nih.gov/pubmed/24065801 http://dx.doi.org/10.2337/db13-0891

Ejemplares similares

Response to Comment on: Tessari et al. Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo. Diabetes 2013;62:2699–2708
por: Tessari, Paolo
Publicado: (2013)

Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Gylfe, Erik
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Schalkwijk, Casper G., et al.
Publicado: (2013)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
por: Surdacki, Andrzej, et al.
Publicado: (2013)

Response to Comment on: Allister et al. UCP2 Regulates the Glucagon Response to Fasting and Starvation. Diabetes 2013;62:1623–1633
por: Hardy, Alexandre B., et al.
Publicado: (2013)

Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Comment on: Lazo et al. NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes. Diabetes 2013;62:3189–3193
por: Moro, Cedric, et al.
Publicado: (2013)

Comment on: Sitnick et al. Skeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity. Diabetes 2013;62:3350–3361
por: Moro, Cedric, et al.
Publicado: (2013)

Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Response to Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
por: Korpos, Éva, et al.
Publicado: (2013)

Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134
por: Jandeleit-Dahm, Karin A.M., et al.
Publicado: (2013)

Comment on: Takeda et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice. Diabetes 2013;62:223–233
por: Chhabra, Kavaljit H., et al.
Publicado: (2013)

Response to Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134
por: Sukumar, Piruthivi, et al.
Publicado: (2013)

Response to Comment on: Takeda et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice. Diabetes 2013;62:223–233
por: Yamamoto, Koichi, et al.
Publicado: (2013)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Heine, Robert J., et al.
Publicado: (2013)

Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Engel, Samuel S., et al.
Publicado: (2013)

Reponse to Comments on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Butler, Alexandra E., et al.
Publicado: (2013)

Systemic regulation of the age-related decline of pancreatic β-cell replication. Diabetes 2013;62:2843–2848
por: Salpeter, SJ, et al.
Publicado: (2013)

A modified Tessari method for producing more foam
por: Xu, Jie, et al.
Publicado: (2016)

Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine
por: Uzar, Ertugrul, et al.
Publicado: (2011)

Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
por: Davis, Joshua S., et al.
Publicado: (2011)

Roles of Nitric Oxide and Asymmetric Dimethylarginine in Pregnancy and Fetal Programming
por: Huang, Li-Tung, et al.
Publicado: (2012)

Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents
por: JaŸwińska-Kozuba, Aleksandra, et al.
Publicado: (2012)

Erratum. The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth. Diabetes 2013;62:2958–2967
por: Gordon, Scott M., et al.
Publicado: (2016)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Restoration of Asymmetric Dimethylarginine–Nitric Oxide Balance to Prevent the Development of Hypertension
por: Tain, You-Lin, et al.
Publicado: (2014)

Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo
por: Tessari, Paolo, et al.
Publicado: (2013)

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
por: Sulicka, Joanna, et al.
Publicado: (2012)

Asymmetric Dimethylarginine Blocks Nitric Oxide-Mediated Alcohol-Stimulated Cilia Beating
por: Wyatt, T. A., et al.
Publicado: (2013)

Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
por: Hsu, Chiao‐Po, et al.
Publicado: (2016)

The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes 2013;62:531–542
por: Korpos, É, et al.
Publicado: (2013)

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
por: Weil, E. Jennifer, et al.
Publicado: (2018)

Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode
por: Ustundag, Mehmet F., et al.
Publicado: (2020)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals
por: Badran, Mohammad, et al.
Publicado: (2015)

Erratum. Weight Loss After Bariatric Surgery Reverses Insulin-Induced Increases in Brain Glucose Metabolism of the Morbidly Obese. Diabetes 2013;62:2747–2751
por: Tuulari, Jetro J., et al.
Publicado: (2017)

Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine in Vascular Endothelial Cells
por: Jung, Chang Hee, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s0b7iq88ooh32hep4umb69fhc4